ATOS - Company ID 0001488039
The table below shows ATOSSA THERAPEUTICS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $21.18M | $14.12M | $17.33M | $15.08M | $9.21M | $6.61M |
| SG&A | $15.96M |
ATOSSA THERAPEUTICS, INC. reported annual revenue of $1.76K for fiscal year 2015. That is down 95.6% from $40.14K in fiscal 2014. Over the 5 fiscal years shown, annual revenue grew from $1.50K (FY 2011) to $1.76K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $13.50M |
| $14.04M |
| $12.61M |
| $11.31M |
| $8.00M |
| Operating income | -$37.14M | -$27.62M | -$31.38M | -$27.69M | -$20.52M | -$14.61M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M |
| EPS (diluted) | -$4.04 | -$3.04 | -$0.24 | -$0.21 | - | - |